David Coles has been involved in the finance field for many years and served as the Interim CEO of MiMedx Group, Inc. from July 2018 to May 2019. His compensation during this time came from the firm Alvarez & Marsal,...

David Coles has been involved in the finance field for many years and served as the Interim CEO of MiMedx Group, Inc. from July 2018 to May 2019. His compensation during this time came from the firm Alvarez & Marsal, which received about $908,663 for his services. This model is interesting because it shows that he wasn't directly on the company's payroll but was hired through a consulting firm. Before MiMedx, Coles worked with Cheche Group Inc. for a brief stint in 2015. Throughout his career, he has emphasized performance-driven success. Interestingly, in 2015, when he was directly employed by MiMedx, his total package reached about $1.5 million, thanks to his performance bonuses and vested stock, showcasing how the company rewards its leadership based on growth metrics. This mix of consulting and executive roles speaks to a flexible approach to corporate leadership.

Quick Links

1. Rivals

2. Holdings

3. Insider Trading

4. Compensation History

5. Other MiMedx Group CEOs

M

David Coles

Ex-CEO of MiMedx Group

Education

Not specified

Field of Expertise

Finance & Banking - Finance

Sector of Economy

Healthcare

Born

January 1, 1965 - 60 years ago

CEO of MiMedx Group for

0 years 10 months (Jul 2018 - May 2019)

Previous Experience

Managing Director with Alvarez & Marsal; CRO of Walter Investment Management, Inc.; interim CEO of Campus Crest Communities, Inc.; CFO of PHH Corp; CFO of Lehman Brothers Holdings Inc.

Rivals

Competitors/colleagues of David Coles

Holdings

See how much did David Coles make over time.

David Coles's wealth in holdings has varied quite a bit during his career. He has had significant stakes in MiMedx Group, especially during his time as Interim CEO. At one point, his total package in 2015 was around $1.5 million,...

David Coles's wealth in holdings has varied quite a bit during his career. He has had significant stakes in MiMedx Group, especially during his time as Interim CEO. At one point, his total package in 2015 was around $1.5 million, boosted by performance bonuses of over $1 million. However, after 2019, his holdings seem to have shifted significantly since he was employed through Alvarez & Marsal, leading to no direct ownership in MiMedx's stock. His financial interests evolved, particularly as he transitioned to roles that depended more on consulting fees rather than traditional equity or salary structures. It's notable that his flexibility in employment arrangements may reflect strategic financial management decisions over time.

Loading...

Insider Trading

See recent insider trades of David Coles.

No insider trades found for this CEO.

Compensation History

See how much did David Coles make over time.

David Coles's compensation has seen some interesting dynamics depending on his employment structure. In 2019, he did not receive direct compensation from MiMedx; rather, he was compensated through Alvarez & Marsal, which billed the company $908,663. This was a major shift from 2015 when he earned around $1.5 million, which included a salary, performance bonuses, and vested stock awards. In fact, the performance-based bonuses made up a large portion of his earnings back then, reflecting the company's goals around revenue and EBITDA. His unique position as an Interim CEO that was indirectly compensated illustrates how companies can structure leadership roles depending on circumstances and needs.

Year

2019

Total Compensation

$0.00

Salary

$0.00

Board Justification

The Company compensates its executives through a combination of salary, bonuses, and equity awards, but Mr. Coles was not part of this structure as he was employed by Alvarez & Marsal.

Bonus

$0.00

Board Justification

No bonuses were awarded to Mr. Coles for the year 2019 as he was not directly compensated by the Company but through Alvarez & Marsal.

Other

$0.00

Board Justification

Mr. Coles was compensated through Alvarez & Marsal, which received $908,663 for his services in 2019.

Restricted Stock

$0.00(0 N/A)

Board Justification

No stock awards were granted to Mr. Coles as he was employed by Alvarez & Marsal and did not receive any stock from MiMedx.

Performance Metrics

N/A

Other MiMedx Group CEOs

Here are other CEOs of MiMedx Group

Parker H. "Pete" Petit

Founder and Ex-CEO of MiMedx Group

February 2009 - June 2018

Timothy R. Wright

Ex-CEO of MiMedx Group

May 2019 - March 2020